National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 20701 [2021-08251]
Download as PDF
<![CDATA[
20701
Federal Register / Vol. 86, No. 75 / Wednesday, April 21, 2021 / Notices
requires each state to cooperate with
any other state in using the federal
forms for issuance of administrative
subpoenas and imposition of liens in
interstate child support cases.
Respondents: State, local, or tribal
agencies administering a child support
enforcement program under title IV–D
of the Social Security Act.
ANNUAL BURDEN ESTIMATES
Annual
number of
respondents
Instrument
Administrative Subpoena .................................................................................
Notice of Lien ...................................................................................................
27,763
1,786,988
Dated: April 16, 2021.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
Estimated Total Annual Burden
Hours: 907,376.
Authority: 42 U.S.C. 652; 42 U.S.C. 654.
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2021–08245 Filed 4–20–21; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2021–08249 Filed 4–20–21; 8:45 am]
BILLING CODE 4184–41–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Average
burden hours
per response
1
1
Annual burden
hours
.50
.50
Dated: April 15, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–08251 Filed 4–20–21; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Library of
Medicine Special Emphasis Panel; T15.
Date: July 23, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Video Assisted Meeting.
Contact Person: Leonid V. Tsap, Ph.D.,
Scientific Review Officer, Extramural
Programs, National Library of Medicine, NIH,
6705 Rockledge Drive, Suite 500, Bethesda,
MD 20892–7968, 301–827–7077, tsapl@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.879, Medical Library
Assistance, National Institutes of Health,
HHS)
VerDate Sep<11>2014
18:12 Apr 20, 2021
Jkt 253001
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; PAR21–082, NIAID SBIR
Phase II Clinical Trial Implementation
Cooperative Agreement (U44 Clinical Trial
Required).
Date: May 14, 2021.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F52,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Jennifer H. Meyers, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3F52, Rockville, MD
20852, 301–761–6602, jennifer.meyers@
nih.gov.
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
13,882
893,494
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Library of Medicine; Notice of
Closed Meetings
khammond on DSKJM1Z7X2PROD with NOTICES
Annual
number of
responses per
respondent
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the
cooperative agreements, the disclosure
of which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Pane; NIAID Clinical Trial
Implementation Cooperative Agreements
(U01) and SBIR Phase II Clinical Trial
Implementation Cooperative Agreements
(U44).
Date: May 18, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3E70A,
Rockville, MD 20892 (Virtual Meeting).
E:\FR\FM\21APN1.SGM
21APN1
]]>Agencies
[Federal Register Volume 86, Number 75 (Wednesday, April 21, 2021)]
[Notices]
[Page 20701]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-08251]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; PAR21-082, NIAID SBIR Phase II
Clinical Trial Implementation Cooperative Agreement (U44 Clinical
Trial Required).
Date: May 14, 2021.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3F52,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Jennifer H. Meyers, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3F52,
Rockville, MD 20852, 301-761-6602, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: April 15, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-08251 Filed 4-20-21; 8:45 am]
BILLING CODE 4140-01-P
